Targeting Interferon Shows Promise in Lupus (CME/CE)

(MedPage Today) -- Sifalimumab effective in a phase IIb trial, particularly for skin manifestations

Source: MedPage Today Rheumatology - March 25, 2016 Category: Rheumatology Source Type: news